Data as of 4:02pm ET
| -0.07 / -0.19%|
The 8 analysts offering 12-month price forecasts for Wuxi Pharmatech Cayman Inc have a median target of 41.50, with a high estimate of 45.00 and a low estimate of 38.00. The median estimate represents a +9.93% increase from the last price of 37.75.
The current consensus among 10 polled investment analysts is to Buy stock in Wuxi Pharmatech Cayman Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.